摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7-(2-methoxyphenyl)heptanoic acid | 21527-30-0

中文名称
——
中文别名
——
英文名称
7-(2-methoxyphenyl)heptanoic acid
英文别名
7-(2-Methoxy-phenyl)-heptanoic acid;7-(2-Methoxy-phenyl)-heptansaeure
7-(2-methoxyphenyl)heptanoic acid化学式
CAS
21527-30-0
化学式
C14H20O3
mdl
——
分子量
236.311
InChiKey
JPUWBGZATHHUFT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    384.8±25.0 °C(Predicted)
  • 密度:
    1.057±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4.1
  • 重原子数:
    17
  • 可旋转键数:
    8
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    46.5
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    7-(2-methoxyphenyl)heptanoic acid草酰氯 作用下, 生成 7-(2-methoxyphenyl)-1-(5-(pyridin-2-yl)oxazol-2-yl)heptan-1-one
    参考文献:
    名称:
    Structure−Activity Relationships of α-Ketooxazole Inhibitors of Fatty Acid Amide Hydrolase
    摘要:
    A systematic study of the structure-activity relationships of 2b (OL-135), a potent inhibitor of fatty acid amide hydrolase (FAAH), is detailed targeting the C2 acyl side chain. A series of aryl replacements or substituents for the terminal phenyl group provided effective inhibitors (e.g., 5c, aryl = 1- napthyl, K-i = 2.6 nM), with 5hh (aryl = 3-ClPh, K-i = 900 pM) being 5-fold more potent than 2b. Conformationally restricted C2 side chains were examined, and many provided exceptionally potent inhibitors, of which 11j (ethylbiphenyl side chain) was established to be a 750 pM inhibitor. A systematic series of heteroatoms (O, NMe, S), electron-withdrawing groups (SO, SO2), and amides positioned within and hydroxyl substitutions on the linking side chain were investigated, which typically led to a loss in potency. The most tolerant positions provided effective inhibitors (12p, 6-position S, K-i = 3 nM, or 13d, 2-position OH, K-i = 8 nM) comparable in potency to 2b. Proteome-wide screening of selected inhibitors from the systematic series of > 100 candidates prepared revealed that they are selective for FAAH over all other mammalian serine proteases.
    DOI:
    10.1021/jm061414r
  • 作为产物:
    描述:
    (5-羧基戊基)三苯基溴化磷 在 palladium on activated charcoal potassium tert-butylate氢气 作用下, 以 四氢呋喃乙酸乙酯 为溶剂, 反应 24.0h, 生成 7-(2-methoxyphenyl)heptanoic acid
    参考文献:
    名称:
    Structure−Activity Relationships of α-Ketooxazole Inhibitors of Fatty Acid Amide Hydrolase
    摘要:
    A systematic study of the structure-activity relationships of 2b (OL-135), a potent inhibitor of fatty acid amide hydrolase (FAAH), is detailed targeting the C2 acyl side chain. A series of aryl replacements or substituents for the terminal phenyl group provided effective inhibitors (e.g., 5c, aryl = 1- napthyl, K-i = 2.6 nM), with 5hh (aryl = 3-ClPh, K-i = 900 pM) being 5-fold more potent than 2b. Conformationally restricted C2 side chains were examined, and many provided exceptionally potent inhibitors, of which 11j (ethylbiphenyl side chain) was established to be a 750 pM inhibitor. A systematic series of heteroatoms (O, NMe, S), electron-withdrawing groups (SO, SO2), and amides positioned within and hydroxyl substitutions on the linking side chain were investigated, which typically led to a loss in potency. The most tolerant positions provided effective inhibitors (12p, 6-position S, K-i = 3 nM, or 13d, 2-position OH, K-i = 8 nM) comparable in potency to 2b. Proteome-wide screening of selected inhibitors from the systematic series of > 100 candidates prepared revealed that they are selective for FAAH over all other mammalian serine proteases.
    DOI:
    10.1021/jm061414r
点击查看最新优质反应信息

文献信息

  • Compounds and inhibitors of phospholipases
    申请人:——
    公开号:US20040033995A1
    公开(公告)日:2004-02-19
    The present invention relates generally to amino acid derivatives and to methods of making the same. In particular, the invention relates to compounds bearing a stereochemical identity, that is, the same stereochemistry, with the chiral &agr;-carbon of D-&agr;-amino acids and their use in methods of therapy, including the treatment of inflammatory diseases, and to compositions and enantiomeric mixtures containing them.
    本发明一般涉及氨基酸生物及其制备方法。具体而言,该发明涉及具有立体化学特性的化合物,即与D-α-氨基酸的手性α-碳具有相同立体化学的化合物,以及它们在治疗方法中的应用,包括治疗炎症性疾病,以及含有它们的组合物和对映体混合物。
  • [EN] COMPOUNDS AND INHIBITORS OF PHOSPHOLIPASES<br/>[FR] COMPOSES ET INHIBITEURS DE PHOSPHOLIPASES
    申请人:UNIV QUEENSLAND
    公开号:WO2002008189A1
    公开(公告)日:2002-01-31
    The present invention relates generally to amino acid derivatives and to methods of making the same. In particular, the invention relates to compounds bearing a stereochemical identity, that is, the same stereochemistry, with the chiral α-carbon of D-α-amino acids and their use in methods of therapy, including the treatment of inflammatory diseases, and to compositions and enantiomeric mixtures containing them.
    本发明通常涉及氨基酸生物及其制备方法。特别地,本发明涉及具有立体化学同一性的化合物,即具有D-α-氨基酸的手性α-碳的同一立体化学,以及它们在治疗方法中的使用,包括治疗炎症性疾病,以及含有它们的组合物和对映体混合物。
  • TRICYCLIC INHIBITORS OF FATTY ACID AMIDE HYDROLASE
    申请人:Boger Dale L.
    公开号:US20100216750A1
    公开(公告)日:2010-08-26
    A series of substituted oxazole compounds having an alpha keto side chain at the 2 position and an aromatic, heteroaromatic or heterocycle substituent at the 5 position are disclosed. These compounds exhibit inhibition of fatty acid amid hydrolase and arc useful for treatment of malconditions involving that enzyme.
    本发明揭示了一系列取代的噁唑化合物,其中在2位具有α-酮基侧链,在5位具有芳香、杂芳或杂环取代基。这些化合物表现出脂肪酸酰胺解酶的抑制作用,并且对于治疗涉及该酶的恶性状况是有用的。
  • COMPOUNDS AND INHIBITORS OF PHOSPHOLIPASES
    申请人:THE UNIVERSITY OF QUEENSLAND
    公开号:EP1309552A1
    公开(公告)日:2003-05-14
  • EP1309552A4
    申请人:——
    公开号:EP1309552A4
    公开(公告)日:2005-07-20
查看更多

同类化合物

(R)-3-(叔丁基)-4-(2,6-二异丙氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (2S,3R)-3-(叔丁基)-2-(二叔丁基膦基)-4-甲氧基-2,3-二氢苯并[d][1,3]氧杂磷杂戊环 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2R,2''R,3R,3''R)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2-氟-3-异丙氧基苯基)三氟硼酸钾 (+)-6,6'-{[(1R,3R)-1,3-二甲基-1,3基]双(氧)}双[4,8-双(叔丁基)-2,10-二甲氧基-丙二醇 麦角甾烷-6-酮,2,3,22,23-四羟基-,(2a,3a,5a,22S,23S)- 鲁前列醇 顺式6-(对甲氧基苯基)-5-己烯酸 顺式-铂戊脒碘化物 顺式-四氢-2-苯氧基-N,N,N-三甲基-2H-吡喃-3-铵碘化物 顺式-4-甲氧基苯基1-丙烯基醚 顺式-2,4,5-三甲氧基-1-丙烯基苯 顺式-1,3-二甲基-4-苯基-2-氮杂环丁酮 非那西丁杂质7 非那西丁杂质3 非那西丁杂质22 非那西丁杂质18 非那卡因 非布司他杂质37 非布司他杂质30 非布丙醇 雷诺嗪 阿达洛尔 阿达洛尔 阿莫噁酮 阿莫兰特 阿维西利 阿索卡诺 阿米维林 阿立酮 阿曲汀中间体3 阿普洛尔 阿普斯特杂质67 阿普斯特中间体 阿普斯特中间体 阿托西汀EP杂质A 阿托莫西汀杂质24 阿托莫西汀杂质10 阿托莫西汀EP杂质C 阿尼扎芬 阿利克仑中间体3 间苯胺氢氟乙酰氯 间苯二酚二缩水甘油醚 间苯二酚二异丙醇醚 间苯二酚二(2-羟乙基)醚 间苄氧基苯乙醇 间甲苯氧基乙酸肼 间甲苯氧基乙腈 间甲苯异氰酸酯